|
Ibiden Co., Ltd. (4062.t) valoración de DCF |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Ibiden Co.,Ltd. (4062.T) Bundle
Diseñado para la precisión, nuestro Ibiden Co., Ltd. (4062t) La calculadora DCF le permite evaluar la valoración de la Compañía utilizando datos financieros del mundo real, ofreciendo una flexibilidad completa para modificar todos los parámetros clave para las proyecciones mejoradas.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 323,461.0 | 401,138.0 | 417,549.0 | 370,511.0 | 369,436.0 | 384,721.5 | 400,639.3 | 417,215.8 | 434,478.2 | 452,454.8 |
| Revenue Growth, % | 0 | 24.01 | 4.09 | -11.27 | -0.29014 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 |
| EBITDA | 67,859.0 | 112,483.0 | 127,283.0 | 94,420.0 | 106,963.0 | 103,059.3 | 107,323.4 | 111,763.9 | 116,388.1 | 121,203.7 |
| EBITDA, % | 20.98 | 28.04 | 30.48 | 25.48 | 28.95 | 26.79 | 26.79 | 26.79 | 26.79 | 26.79 |
| Depreciation | 35,434.0 | 52,807.0 | 55,014.0 | 46,032.0 | 54,205.0 | 49,545.0 | 51,594.9 | 53,729.6 | 55,952.7 | 58,267.7 |
| Depreciation, % | 10.95 | 13.16 | 13.18 | 12.42 | 14.67 | 12.88 | 12.88 | 12.88 | 12.88 | 12.88 |
| EBIT | 32,425.0 | 59,676.0 | 72,269.0 | 48,388.0 | 52,758.0 | 53,514.3 | 55,728.5 | 58,034.3 | 60,435.4 | 62,936.0 |
| EBIT, % | 10.02 | 14.88 | 17.31 | 13.06 | 14.28 | 13.91 | 13.91 | 13.91 | 13.91 | 13.91 |
| Total Cash | 126,884.0 | 185,592.0 | 302,419.0 | 443,583.0 | 390,656.0 | 275,399.4 | 286,794.1 | 298,660.2 | 311,017.3 | 323,885.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 89,687.0 | 91,989.0 | 79,446.0 | 65,330.0 | 68,131.0 | 81,376.6 | 84,743.5 | 88,249.8 | 91,901.1 | 95,703.6 |
| Account Receivables, % | 27.73 | 22.93 | 19.03 | 17.63 | 18.44 | 21.15 | 21.15 | 21.15 | 21.15 | 21.15 |
| Inventories | 57,023.0 | 74,566.0 | 79,194.0 | 65,318.0 | 67,175.0 | 70,016.5 | 72,913.4 | 75,930.2 | 79,071.8 | 82,343.4 |
| Inventories, % | 17.63 | 18.59 | 18.97 | 17.63 | 18.18 | 18.2 | 18.2 | 18.2 | 18.2 | 18.2 |
| Accounts Payable | 45,717.0 | 51,150.0 | 28,262.0 | 43,875.0 | 38,761.0 | 43,078.9 | 44,861.3 | 46,717.5 | 48,650.4 | 50,663.3 |
| Accounts Payable, % | 14.13 | 12.75 | 6.77 | 11.84 | 10.49 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 |
| Capital Expenditure | -76,523.0 | -67,214.0 | -104,032.0 | -86,422.0 | -197,484.0 | -109,344.7 | -113,868.9 | -118,580.2 | -123,486.5 | -128,595.7 |
| Capital Expenditure, % | -23.66 | -16.76 | -24.91 | -23.33 | -53.46 | -28.42 | -28.42 | -28.42 | -28.42 | -28.42 |
| Tax Rate, % | 34.49 | 34.49 | 34.49 | 34.49 | 34.49 | 34.49 | 34.49 | 34.49 | 34.49 | 34.49 |
| EBITAT | 25,905.7 | 41,527.1 | 52,599.7 | 32,122.7 | 34,560.2 | 37,905.0 | 39,473.3 | 41,106.6 | 42,807.3 | 44,578.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -116,176.3 | 12,708.1 | -11,391.3 | 35,337.7 | -118,490.8 | -33,663.8 | -27,282.1 | -28,410.9 | -29,586.4 | -30,810.6 |
| WACC, % | 6.27 | 6.17 | 6.2 | 6.14 | 6.13 | 6.18 | 6.18 | 6.18 | 6.18 | 6.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -125,730.5 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | -31,735 | |||||||||
| Terminal Value | -996,869 | |||||||||
| Present Terminal Value | -738,505 | |||||||||
| Enterprise Value | -864,236 | |||||||||
| Net Debt | -47,596 | |||||||||
| Equity Value | -816,640 | |||||||||
| Diluted Shares Outstanding, MM | 147 | |||||||||
| Equity Value Per Share | -5,538.08 |
What You Will Receive
- Genuine Ibiden Data: Preloaded financials – encompassing everything from revenue to EBIT – based on real and projected figures.
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates to suit your analysis.
- Immediate Valuation Updates: Automatic recalculations to assess the effects of changes on Ibiden’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario testing, and thorough projections.
- Efficient and Reliable: Avoid the hassle of building models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Ibiden Co., Ltd. (4062T).
- WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with customizable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to suit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Ibiden Co., Ltd. (4062T).
- Visual Dashboard and Charts: Provides graphical representations of key valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel file for Ibiden Co.,Ltd. (4062T).
- Step 2: Review the pre-populated data on Ibiden's historical and projected performance.
- Step 3: Modify key assumptions (highlighted in yellow) according to your analysis.
- Step 4: Observe the automatic recalculations reflecting Ibiden’s intrinsic value.
- Step 5: Utilize the results for investment decisions or reporting purposes.
Why Opt for This Calculator for Ibiden Co., Ltd. (4062T)?
- Precision: Authentic financial data for Ibiden Co., Ltd. ensures reliable results.
- Versatility: Tailored for users to easily test and adjust inputs as needed.
- Efficiency: Eliminate the time-consuming process of constructing a DCF model from the ground up.
- High-Quality: Crafted with executive-level precision and a focus on usability.
- Intuitive: Simple to navigate, even for those new to financial modeling.
Who Can Benefit from This Product?
- Investors: Accurately assess Ibiden Co., Ltd.'s fair value before proceeding with investment choices.
- CFOs: Utilize a top-tier DCF model for comprehensive financial reporting and analysis.
- Consultants: Effortlessly customize the template for creating valuation reports for clients.
- Entrepreneurs: Discover financial modeling strategies employed by leading companies in the industry.
- Educators: Implement it as an educational resource to showcase various valuation techniques.
Contents of the Template
- Pre-Filled DCF Model: Ibiden Co., Ltd.'s financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess Ibiden's profitability, leverage, and operational efficiency.
- Editable Inputs: Customize assumptions such as growth rates, profit margins, and CAPEX to suit your scenarios.
- Financial Statements: Access annual and quarterly reports for in-depth financial analysis.
- Interactive Dashboard: Visualize crucial valuation metrics and outputs with ease.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.